"I didn't go through medical school. But I also believe you shouldn't have to get a PhD to save your own life."
Blockages on
initial diagnosis
To achieve
full reversal
Current world
cycling record
Age at latest
world record
Diagnosed with inoperable coronary blockages at 55. Three years later: zero ischemia on stress testing, VO₂ Max up 20%, and on the path to the world stage.
VO₂ Max over 3 years
LDL-C achieved
Peter had been a competitive cyclist for 40 years. He ate carefully. He trained hard. And then his power output quietly started to drop — with no explanation.
Peter noticed an abrupt, unexplained 14% reduction in his cycling power output. His coach said it was aging. He trained harder for four years trying to reverse it — with no improvement. Something was wrong that training couldn’t fix.
"The doctor pointed out three or four blockages of 70 and 90 percent and said they were unable to insert a stent or do bypass surgery due to their location. He looked at me and shrugged."
— Peter Megdal, describing his 2014 diagnosis
With no surgical options, Peter turned to the medical literature. His PhD gave him access to journals most patients never see. What he found changed everything.
"The evidence for reversing heart disease pointed to a low-fat whole-food plant-based diet and a short list of cholesterol-lowering drugs. I was stunned. I grew up in Texas."
— Peter Megdal
"The doctor pointed out three or four blockages of 70 and 90 percent and said they were unable to insert a stent or do bypass surgery due to their location. He looked at me and shrugged."
— Peter Megdal, describing his 2014 diagnosis
Diet alone wasn’t enough. Peter combined aggressive lipid therapy and structured training to create what the published case study calls “optimal medical therapy combined with lifestyle change.”
Strict elimination of all animal products, added oils, and processed foods. Modeled on the research of Ornish, Esselstyn, and Campbell — ultra-low fat, high fiber, zero dietary cholesterol.
Statins caused intolerable muscle pain and reduced cycling performance. Peter petitioned his cardiologist for Repatha (evolocumab) — a PCSK9 inhibitor that disabled the protein destroying his LDL receptors.
Peter never stopped competing. He maintained elite-level cycling training throughout — improving endothelial function through nitric oxide production and using performance as the objective proof of recovery.
Measurement: VO₂ Max and 20-minute maximal power output used as objective markers throughout. Same tests, same protocol, serial measurement — so progress was real and verifiable.
Get notified about new articles.